| Schedule of Cash Equivalents and Available-for-Sale Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
|
Amortized Cost |
|
Gross Unrealized
Gains |
|
Gross Unrealized
Losses |
|
Fair Value |
|
Cash Equivalents |
|
Short-Term
Investments |
|
Long-Term
Investments |
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds |
$ |
682,000 |
|
$ |
— |
|
$ |
— |
|
$ |
682,000 |
|
$ |
682,000 |
|
$ |
— |
|
$ |
— |
Subtotal |
|
682,000 |
|
|
— |
|
|
— |
|
|
682,000 |
|
|
682,000 |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Notes/Bonds |
|
2,895,000 |
|
|
— |
|
|
(56,000) |
|
|
2,839,000 |
|
|
— |
|
|
787,000 |
|
|
2,052,000 |
Subtotal |
|
2,895,000 |
|
|
— |
|
|
(56,000) |
|
|
2,839,000 |
|
|
— |
|
|
787,000 |
|
|
2,052,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
$ |
3,577,000 |
|
$ |
— |
|
$ |
(56,000) |
|
$ |
3,521,000 |
|
$ |
682,000 |
|
$ |
787,000 |
|
$ |
2,052,000 |
|
| Schedule of Estimated Fair Value of Available-for-Sale Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortized Cost |
|
Estimated Market
Value |
Due within one year |
|
$ |
797,000 |
|
$ |
787,000 |
Due after one year through five years |
|
|
2,098,000 |
|
|
2,052,000 |
|
|
$ |
2,895,000 |
|
$ |
2,839,000 |
|